Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $255,645 - $296,631
-2,300 Reduced 47.92%
2,500 $283,000
Q2 2024

Aug 05, 2024

BUY
$123.8 - $132.96 $594,240 - $638,208
4,800 New
4,800 $594,000
Q3 2023

Nov 03, 2023

BUY
$102.95 - $114.33 $936,845 - $1.04 Million
9,100 New
9,100 $936,000
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $3.9 Million - $4.35 Million
-37,900 Reduced 38.67%
60,100 $6.39 Million
Q4 2022

Feb 14, 2023

SELL
$87.44 - $112.11 $60.9 Million - $78.1 Million
-696,600 Reduced 87.67%
98,000 $10.9 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $20.4 Million - $22.9 Million
241,600 Added 43.69%
794,600 $68.4 Million
Q2 2022

Aug 15, 2022

SELL
$83.49 - $94.64 $1 Million - $1.14 Million
-12,000 Reduced 2.12%
553,000 $50.4 Million
Q1 2022

May 17, 2022

BUY
$73.51 - $82.4 $39.4 Million - $44.2 Million
536,200 Added 1861.81%
565,000 $46.4 Million
Q4 2021

Feb 14, 2022

SELL
$72.28 - $90.54 $2.79 Million - $3.49 Million
-38,600 Reduced 57.27%
28,800 $2.21 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $3.04 Million - $3.34 Million
42,400 Added 169.6%
67,400 $5.06 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $393,736 - $435,512
5,600 Added 28.87%
25,000 $1.94 Million
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $13 Million - $14.7 Million
-177,500 Reduced 90.15%
19,400 $1.61 Million
Q2 2020

Aug 14, 2020

SELL
$70.42 - $80.13 $63.6 Million - $72.4 Million
-903,100 Reduced 82.1%
196,900 $15.2 Million
Q1 2020

May 15, 2020

BUY
$63.36 - $87.82 $61.8 Million - $85.6 Million
975,000 Added 780.0%
1,100,000 $84.6 Million
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $1.04 Million - $1.17 Million
-13,400 Reduced 9.68%
125,000 $11.4 Million
Q3 2019

Nov 14, 2019

BUY
$76.08 - $82.93 $10.5 Million - $11.5 Million
138,400 New
138,400 $11.7 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $245B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Capula Management LTD Portfolio

Follow Capula Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.